• About
    Our Story Honorary President Big Issue Team Consultants
  • Investment
    Stretagies Portfolio
  • Pharmacetical
  • Corporate Governance
    Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG
    Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors
    Financials
    Financial Reports Operating Revenue
    Events
    Market Observation Post System
  • News
  • Careers
    Job Openings
  • Contact

繁體中文

News

  • 2021-07-27

    晟德理曼提(Rivast)口服液劑之最新研究獲登國際知名期刊CPN

  • 2021-07-02

    晟德股東會通過配發現金股利1.5元及股票股利1元

  • 2021-05-11

    晟德(4123)110年Q1 EPS達4.63元

  • 2021-04-13

    晟德控股永續金流模式 催生集團生技獨角獸

  • 2021-03-29

    晟德打造永續金流模式 深化核心事業並保持穩定配息 晟德EPS 8.5元 擬配發股利2.5元

  • 2021-01-27

    晟德(4123)宣佈參與永昕(4726)現金增資案

  • 2020-12-24

    晟德集團IPO浪潮來襲 流動性資產大幅提升

  • 2020-12-21

    晟德轉投資公司加科思正式於香港敲鐘上市

  • 2020-11-24

    【代轉發】林榮錦針對鏡週刊2020.11.24報導的聲明 - 無中生有 再三造謠 可悲東洋

  • 2020-11-12

    晟德公佈2020年第三季合併財務報告

1 上一頁 6 7 8 9 10 下一頁 18

HEAD OFFICE
TEL:+886 2 2655-8680
FAX:+886 2 2655-8380
7F., No.3-2, Park St., Nangang Dist.,
Taipei City 115, Taiwan (R.O.C.)

  • About Our Story Honorary President Big Issue Team Consultants
  • Investment Stretagies Portfolio
    Pharmacetical
  • Corporate Governance Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors Financial Reports Operating Revenue Events Market Observation Post System
  • News
    Careers Job Openings
    Contact
Copyright © 2018 Center Ventures All right reserved. Web Design By rIDEA